Literature DB >> 32247381

The COVID-19 pandemic in the USA: what might we expect?

Gerardo Chowell1, Kenji Mizumoto2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32247381      PMCID: PMC7270048          DOI: 10.1016/S0140-6736(20)30743-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
As of March 19, 2020, 191 127 cases of, including 7807 deaths attributed to, coronavirus disease 2019 (COVID-19) have been reported worldwide. The incidence of reported cases in China has dramatically reduced to tens per day as a result of strict social distancing measures; however, the pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now generating sustained transmission in many countries including the USA. In The Lancet, Isaac Ghinai, Tristan D McPherson, and colleagues report details of the first known human-to-human transmission of SARS-CoV-2 in the USA, which was identified in late January, 2020. An infected traveller, a woman in her 60s, returned from Wuhan and subsequently became symptomatic and transmitted the infection to her husband with whom she had prolonged and unprotected contact. An investigation of 350 contacts of both patients did not lead to any additional cases. However, we cannot rule out the possibility that some asymptomatic contacts went undetected, because the proportion of asymptomatic COVID-19 cases appears to be large. For example, estimated asymptomatic proportion was 18% for the outbreak on the Diamond Princess cruise ship. In the USA, where influenza activity is still widespread, 3499 cases, including 60 deaths, have been attributed to COVID-19 as of March 15, 2020. Most cases have been reported in New York (20·1%), Washington (18·4%), and California (12·2%), but the epidemic is still unravelling as testing becomes broadly available across the country. Although it is impossible to predict which areas of the USA will fare better or worse with regard to COVID-19, past influenza pandemics in the USA have generated substantial spatial heterogeneity in mortality. For example, all-cause mortality for the 1918–20 influenza pandemic ranged from 0·25% in Wisconsin to 0·84% in Arizona.6, 7 Furthermore, older populations in some areas tended to exhibit lower excess mortality, which might have resulted from protection provided by previous exposure to a similar virus. In contrast, the risk of death from COVID-19 increases with older age, suggesting that Florida, Maine, and Puerto Rico, which have the populations with the largest proportions of older people (≥65 years), might be the most vulnerable to this pandemic virus. On March 13, 2020, President Donald Trump declared a national emergency to combat the spread of COVID-19 in the USA, which led to a range of social distancing interventions across the country, including closures of schools, bars, cinemas, and restaurants, cancellation of large public gatherings, including cultural and sporting events, and discouraging gatherings of more than 50 people. Moreover, an increasing number of businesses and companies have asked their employees to work remotely. These social distancing measures are reducing the transmission rate of the virus and, in turn, reducing the risk of death for the most vulnerable populations. During the influenza 2009 A/H1N1 pandemic, the implementation of social distancing interventions, including nationwide school closures and cancellation of public gatherings, was associated with a 30% reduction in the transmission rate. However, it increased after the mandatory school suspension resumed and before summer vacation started. Given the uncertainties surrounding the extent of the COVID-19 pandemic across the country, efforts to sustain online learning and remote working in combination with enhanced infection control measures in health-care settings and nursing homes could aid in mitigating the spread of the virus and gaining control of the epidemic's chains of transmission. In the USA, past influenza pandemics have spread as a series of waves of varying durations and intensities, which have been associated with seasons and school cycles.10, 11 Because respiratory viruses, including other coronaviruses, are known to respond to seasonal variation, we might expect that increasing temperatures in the summer could reduce the intrinsic transmissibility of the novel coronavirus to some extent. In the context of a novel virus, warmer weather alone is unlikely to sufficiently mitigate the transmission rate and interrupt community transmission in the absence of social distancing strategies. Perhaps the most reasonable scenario ahead of us is that the transmission rate will decline during the next few months, partly driven by social distancing measures, a scenario that is reminiscent of the influenza 2009 A/H1N1 pandemic. Close monitoring of the transmission potential of the virus on the basis of reliable and publicly available data in near real-time will be key to short-term forecasts and sound public health decisions.
  9 in total

1.  Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City.

Authors:  Donald R Olson; Lone Simonsen; Paul J Edelson; Stephen S Morse
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

2.  Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis.

Authors:  Christopher J L Murray; Alan D Lopez; Brian Chin; Dennis Feehan; Kenneth H Hill
Journal:  Lancet       Date:  2006-12-23       Impact factor: 79.321

3.  Excess mortality patterns during 1918-1921 influenza pandemic in the state of Arizona, USA.

Authors:  Sushma Dahal; Melinda Jenner; Linh Dinh; Kenji Mizumoto; Cecile Viboud; Gerardo Chowell
Journal:  Ann Epidemiol       Date:  2017-12-21       Impact factor: 3.797

4.  School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States.

Authors:  Dennis L Chao; M Elizabeth Halloran; Ira M Longini
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

5.  Potential impact of seasonal forcing on a SARS-CoV-2 pandemic.

Authors:  Richard A Neher; Robert Dyrdak; Valentin Druelle; Emma B Hodcroft; Jan Albert
Journal:  Swiss Med Wkly       Date:  2020-03-16       Impact factor: 2.193

6.  Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico.

Authors:  Gerardo Chowell; Santiago Echevarría-Zuno; Cécile Viboud; Lone Simonsen; James Tamerius; Mark A Miller; Víctor H Borja-Aburto
Journal:  PLoS Med       Date:  2011-05-24       Impact factor: 11.069

7.  First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.

Authors:  Isaac Ghinai; Tristan D McPherson; Jennifer C Hunter; Hannah L Kirking; Demian Christiansen; Kiran Joshi; Rachel Rubin; Shirley Morales-Estrada; Stephanie R Black; Massimo Pacilli; Marielle J Fricchione; Rashmi K Chugh; Kelly A Walblay; N Seema Ahmed; William C Stoecker; Nausheen F Hasan; Deborah P Burdsall; Heather E Reese; Megan Wallace; Chen Wang; Darcie Moeller; Jacqueline Korpics; Shannon A Novosad; Isaac Benowitz; Max W Jacobs; Vishal S Dasari; Megan T Patel; Judy Kauerauf; E Matt Charles; Ngozi O Ezike; Victoria Chu; Claire M Midgley; Melissa A Rolfes; Susan I Gerber; Xiaoyan Lu; Stephen Lindstrom; Jennifer R Verani; Jennifer E Layden
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

8.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

9.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

Authors:  Kenji Mizumoto; Katsushi Kagaya; Alexander Zarebski; Gerardo Chowell
Journal:  Euro Surveill       Date:  2020-03
  9 in total
  34 in total

1.  The impact of health status on attitudes toward COVID-19 vaccination.

Authors:  Ashraf Mustafa; Mohammed Safi; Maxwell P Opoku; Ahmed M Mohamed
Journal:  Health Sci Rep       Date:  2022-07-20

2.  Interpreting, analysing and modelling COVID-19 mortality data.

Authors:  Didier Sornette; Euan Mearns; Michael Schatz; Ke Wu; Didier Darcet
Journal:  Nonlinear Dyn       Date:  2020-10-01       Impact factor: 5.022

3.  Rise and Decay of the COVID-19 Epidemics in the USA and the State of New York in the First Half of 2020: A Nonlinear Physics Perspective Yielding Novel Insights.

Authors:  Till D Frank
Journal:  Biomed Res Int       Date:  2021-05-18       Impact factor: 3.411

4.  Volatility estimation for COVID-19 daily rates using Kalman filtering technique.

Authors:  Md Al Masum Bhuiyan; Suhail Mahmud; Md Romyull Islam; Nishat Tasnim
Journal:  Results Phys       Date:  2021-05-18       Impact factor: 4.476

5.  The perceptions of anatomy teachers for different majors during the COVID-19 pandemic: a national Chinese survey.

Authors:  Yu Yan; Xin Cheng; Changman Zhou; Xuesong Yang; Yun-Qing Li
Journal:  Med Educ Online       Date:  2021-12

6.  Cross-sectional analysis and data-driven forecasting of confirmed COVID-19 cases.

Authors:  Nan Jing; Zijing Shi; Yi Hu; Ji Yuan
Journal:  Appl Intell (Dordr)       Date:  2021-07-05       Impact factor: 5.019

Review 7.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

8.  Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.

Authors:  Swayam Prakash; Ruchi Srivastava; Pierre-Gregoire Coulon; Nisha R Dhanushkodi; Aziz A Chentoufi; Delia F Tifrea; Robert A Edwards; Cesar J Figueroa; Sebastian D Schubl; Lanny Hsieh; Michael J Buchmeier; Mohammed Bouziane; Anthony B Nesburn; Baruch D Kuppermann; Lbachir BenMohamed
Journal:  J Immunol       Date:  2021-04-28       Impact factor: 5.426

Review 9.  Challenges amid COVID-19 times - Review of the changing practices in a clinical chemistry laboratory from a developing country.

Authors:  Sibtain Ahmed; Lena Jafri; Hafsa Majid; Aysha Habib Khan; Farooq Ghani; Imran Siddiqui
Journal:  Ann Med Surg (Lond)       Date:  2020-06-06

10.  Dietary Habits before and during the COVID-19 Epidemic in Selected European Countries.

Authors:  Magdalena Skotnicka; Kaja Karwowska; Filip Kłobukowski; Eliza Wasilewska; Sylwia Małgorzewicz
Journal:  Nutrients       Date:  2021-05-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.